Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Daily News

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Michael O'Riordan

January 08, 2026

News Daily News

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

L.A. McKeown

June 05, 2024

News Daily News

Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes

Michael O'Riordan

December 08, 2023

News Daily News

Some Daylight for Vitamin D? New Analysis Hints at Small CVD Benefit

Michael O'Riordan

June 30, 2023

News Daily News

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Michael O'Riordan

December 14, 2022

News Conference News TCT 2021

EXAMINATION Confirms Poor 10-Year Prognosis in Diabetic Patients Post-STEMI

Michael O'Riordan

October 15, 2021

News Daily News

Despite COVID-19, Heart Disease Remains Top US Killer: AHA

Michael O'Riordan

January 28, 2021

News Daily News

LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes

Yael L. Maxwell

September 14, 2020

News Daily News

Age Shouldn’t Be a Barrier to Statin Therapy, Meta-analysis Suggests

Michael O'Riordan

February 08, 2019

News Conference News ESC 2018

Latest SWEDEHEART Data Show Acute MI Mortality Rates Have Stagnated

Todd Neale

September 04, 2018

News Daily News

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

Michael O'Riordan

January 19, 2018

News Daily News

Statins and Diabetes: Causal Link Reinforced in New Analysis

Michael O'Riordan

October 25, 2017

News Daily News

Ischemic Heart Disease the Leading Cause of Death Globally

Michael O'Riordan

September 19, 2017

News Conference News ESC 2017

Ultra-Low LDL Levels? FOURIER Suggests Efficacy of Evolocumab

Michael O'Riordan

August 28, 2017

News Conference News AHA 2015

Knowing Genetic Risk for MI Motivates Patients, Physicians to Get Cholesterol Levels Lower

Yael L. Maxwell

November 08, 2015

Advertisement

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes

Some Daylight for Vitamin D? New Analysis Hints at Small CVD Benefit

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

EXAMINATION Confirms Poor 10-Year Prognosis in Diabetic Patients Post-STEMI

Despite COVID-19, Heart Disease Remains Top US Killer: AHA

LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes

Age Shouldn’t Be a Barrier to Statin Therapy, Meta-analysis Suggests

Latest SWEDEHEART Data Show Acute MI Mortality Rates Have Stagnated

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

Statins and Diabetes: Causal Link Reinforced in New Analysis

Ischemic Heart Disease the Leading Cause of Death Globally

Ultra-Low LDL Levels? FOURIER Suggests Efficacy of Evolocumab

Knowing Genetic Risk for MI Motivates Patients, Physicians to Get Cholesterol Levels Lower

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content